| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.714 | 0.028 | 0.754 | Apoptosis agonist | 0.754 0.023 CID_41322 | CID_41322 | |
| 0.575 | 0.04 | 0.828 | Caspase 9 stimulant | 0.828 0.008 CID_41322 | CID_41322 | |
| 0.464 | 0.006 | 0.464 | Alpha-N-acetylglucosaminidase inhibitor | 0.285 0.018 CID_41322 | ||
| 0.491 | 0.034 | 0.491 | Aldehyde oxidase inhibitor | 0.256 0.08 CID_41322 | ||
| 0.486 | 0.045 | 0.486 | Antibacterial | 0.484 0.045 CID_41322 | ||
| 0.44 | 0.008 | 0.44 | Topoisomerase II inhibitor | 0.364 0.012 CID_41322 | ||
| 0.466 | 0.042 | 0.487 | Immunosuppressant | 0.487 0.037 CID_41322 | CID_41322 | |
| 0.45 | 0.042 | 0.45 | GABA C receptor rho-3 antagonist | 0.3 0.116 CID_41322 | ||
| 0.411 | 0.026 | 0.448 | DNA damaging | 0.448 0.02 CID_41322 | CID_41322 | |
| 0.438 | 0.056 | 0.438 | Histamine release inhibitor | 0.404 0.073 CID_41322 | ||
| 0.436 | 0.058 | 0.436 | 5 Hydroxytryptamine release inhibitor | 0.304 0.161 CID_41322 | ||
| 0.386 | 0.034 | 0.386 | Hypoxia-inducible factor 1 alpha inhibitor | 0.34 0.048 CID_41322 | ||
| 0.337 | 0.008 | 0.337 | Antineoplastic antibiotic | 0.298 0.01 CID_41322 | ||
| 0.358 | 0.029 | 0.358 | DNA synthesis inhibitor | 0.348 0.031 CID_41322 | ||
| 0.376 | 0.051 | 0.376 | Caspase 3 stimulant | 0.346 0.06 CID_41322 | ||
| 0.331 | 0.011 | 0.331 | Alkylator | 0.324 0.011 CID_41322 | ||
| 0.38 | 0.068 | 0.423 | Transcription factor NF kappa B inhibitor | 0.423 0.059 CID_41322 | CID_41322 | |
| 0.311 | 0.005 | 0.311 | ATPase inhibitor | 0.277 0.009 CID_41322 | ||
| 0.339 | 0.035 | 0.503 | Antimitotic | 0.503 0.012 CID_41322 | CID_41322 | |
| 0.305 | 0.011 | 0.305 | DNA intercalator | 0.274 0.014 CID_41322 | ||
| 0.339 | 0.049 | 0.395 | Antioxidant | 0.395 0.036 CID_41322 | CID_41322 | |
| 0.32 | 0.033 | 0.32 | Peroxidase inhibitor | 0.126 0.094 CID_41322 | ||
| 0.393 | 0.107 | 0.393 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.274 0.25 CID_41322 | ||
| 0.307 | 0.022 | 0.307 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.203 0.069 CID_41322 | ||
| 0.284 | 0.011 | 0.284 | Cystathionine beta-synthase inhibitor | 0.222 0.02 CID_41322 | ||
| 0.291 | 0.021 | 0.291 | Neurotrophic factor enhancer | 0.245 0.041 CID_41322 | ||
| 0.276 | 0.013 | 0.317 | Topoisomerase I inhibitor | 0.317 0.009 CID_41322 | CID_41322 | |
| 0.324 | 0.07 | 0.344 | Calcium channel activator | 0.344 0.054 CID_41322 | CID_41322 | |
| 0.29 | 0.038 | 0.29 | Tyrosine 3 hydroxylase inhibitor | 0.218 0.106 CID_41322 | ||
| 0.293 | 0.048 | 0.293 | 5 Hydroxytryptamine uptake stimulant | 0.236 0.096 CID_41322 | ||
| 0.29 | 0.046 | 0.29 | Cyclic AMP phosphodiesterase inhibitor | 0.168 0.125 CID_41322 | ||
| 0.249 | 0.006 | 0.249 | HIV-1 integrase (Strand Transfer) inhibitor | 0.207 0.009 CID_41322 | ||
| 0.277 | 0.034 | 0.33 | Peptidyltransferase inhibitor | 0.33 0.016 CID_41322 | CID_41322 | |
| 0.237 | 0.014 | 0.237 | UDP-glucose 4-epimerase inhibitor | 0.226 0.015 CID_41322 | ||
| 0.229 | 0.008 | 0.229 | MAP3K9 inhibitor | 0.191 0.019 CID_41322 | ||
| 0.273 | 0.055 | 0.273 | Gastrin inhibitor | 0.194 0.158 CID_41322 | ||
| 0.245 | 0.027 | 0.245 | NOS3 expression enhancer | 0.22 0.034 CID_41322 | ||
| 0.263 | 0.045 | 0.263 | Anesthetic general | |||
| 0.229 | 0.014 | 0.251 | Microtubule formation inhibitor | 0.251 0.008 CID_41322 | CID_41322 | |
| 0.284 | 0.075 | 0.284 | 5 Hydroxytryptamine release stimulant | 0.183 0.138 CID_41322 | ||
| 0.251 | 0.049 | 0.251 | RNA-directed DNA polymerase inhibitor | 0.228 0.066 CID_41322 | ||
| 0.211 | 0.014 | 0.211 | Topoisomerase II alpha inhibitor | 0.193 0.016 CID_41322 | ||
| 0.263 | 0.067 | 0.263 | Superoxide dismutase inhibitor | |||
| 0.206 | 0.012 | 0.206 | Photosensitizer | 0.151 0.03 CID_41322 | ||
| 0.194 | 0.003 | 0.194 | ATPase (Vacuolar H+) inhibitor | 0.139 0.01 CID_41322 | ||
| 0.239 | 0.055 | 0.406 | Nitric oxide antagonist | 0.406 0.025 CID_41322 | CID_41322 | |
| 0.208 | 0.025 | 0.208 | Cholesterol synthesis inhibitor | 0.102 0.084 CID_41322 | ||
| 0.214 | 0.036 | 0.214 | Melanin inhibitor | 0.177 0.053 CID_41322 | ||
| 0.21 | 0.033 | 0.21 | Heat shock protein 90 antagonist | |||
| 0.204 | 0.029 | 0.204 | Arachidonic acid antagonist | 0.199 0.034 CID_41322 | ||
| 0.202 | 0.034 | 0.202 | Hexokinase inhibitor | |||
| 0.175 | 0.009 | 0.175 | Ca2+-transporting ATPase inhibitor | 0.166 0.017 CID_41322 | ||
| 0.179 | 0.014 | 0.179 | Triose-phosphate isomerase inhibitor | 0.108 0.04 CID_41322 | ||
| 0.183 | 0.018 | 0.183 | Adenylate kinase inhibitor | 0.12 0.043 CID_41322 | ||
| 0.272 | 0.11 | 0.272 | Cholesterol antagonist | 0.243 0.131 CID_41322 | ||
| 0.221 | 0.059 | 0.221 | Nitric-oxide synthase stimulant | 0.187 0.113 CID_41322 | ||
| 0.176 | 0.015 | 0.176 | Creatine kinase inhibitor | 0.131 0.034 CID_41322 | ||
| 0.169 | 0.008 | 0.169 | Alcohol oxidase inhibitor | 0.064 0.032 CID_41322 | ||
| 0.184 | 0.024 | 0.184 | GABA C receptor agonist | 0.095 0.072 CID_41322 | ||
| 0.183 | 0.023 | 0.183 | Adenylate cyclase stimulant | 0.174 0.031 CID_41322 | ||
| 0.19 | 0.031 | 0.19 | DNA polymerase I inhibitor | 0.141 0.054 CID_41322 | ||
| 0.173 | 0.017 | 0.497 | Estrogen antagonist | 0.497 0.004 CID_41322 | CID_41322 | |
| 0.202 | 0.047 | 0.202 | Succinate dehydrogenase inhibitor | 0.168 0.083 CID_41322 | ||
| 0.167 | 0.014 | 0.167 | NADH dehydrogenase inhibitor | 0.129 0.024 CID_41322 | ||
| 0.171 | 0.022 | 0.171 | Antineoplastic alkaloid | 0.097 0.05 CID_41322 | ||
| 0.169 | 0.022 | 0.169 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.113 0.043 CID_41322 | ||
| 0.245 | 0.098 | 0.245 | Immunostimulant | 0.229 0.105 CID_41322 | ||
| 0.181 | 0.035 | 0.181 | CF transmembrane conductance regulator agonist | |||
| 0.154 | 0.011 | 0.154 | Phenylalanine 4-hydroxylase inhibitor | 0.075 0.042 CID_41322 | ||
| 0.331 | 0.188 | 0.467 | Antiinflammatory | 0.467 0.102 CID_41322 | CID_41322 | |
| 0.156 | 0.014 | 0.545 | Estrogen receptor beta antagonist | 0.545 0.003 CID_41322 | CID_41322 | |
| 0.156 | 0.015 | 0.156 | Anabolic | 0.112 0.047 CID_41322 | ||
| 0.191 | 0.051 | 0.191 | Phospholipase C inhibitor | 0.165 0.079 CID_41322 | ||
| 0.17 | 0.034 | 0.17 | Adenylate cyclase inhibitor | 0.102 0.082 CID_41322 | ||
| 0.256 | 0.122 | 0.256 | Sodium/bile acid cotransporter inhibitor | |||
| 0.165 | 0.038 | 0.165 | MAP kinase kinase 4 inhibitor | 0.132 0.107 CID_41322 | ||
| 0.151 | 0.025 | 0.151 | HIV-1 integrase (Overall Integration) inhibitor | 0.091 0.063 CID_41322 | ||
| 0.144 | 0.019 | 0.144 | Phosphofructokinase-1 inhibitor | 0.136 0.021 CID_41322 | ||
| 0.139 | 0.016 | 0.139 | Lanosterol 14 alpha demethylase inhibitor | 0.097 0.06 CID_41322 | ||
| 0.152 | 0.03 | 0.154 | DNA repair enzyme inhibitor | 0.154 0.028 CID_41322 | CID_41322 | |
| 0.17 | 0.049 | 0.17 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.134 | 0.014 | 0.144 | Estrogen receptor alpha antagonist | 0.144 0.013 CID_41322 | CID_41322 | |
| 0.189 | 0.073 | 0.255 | Hepatoprotectant | 0.255 0.042 CID_41322 | CID_41322 | |
| 0.13 | 0.016 | 0.13 | Glutamate release inhibitor | 0.114 0.027 CID_41322 | ||
| 0.148 | 0.035 | 0.148 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.169 | 0.056 | 0.169 | Protein kinase stimulant | 0.122 0.091 CID_41322 | ||
| 0.166 | 0.054 | 0.166 | GABA C receptor rho-2 antagonist | |||
| 0.123 | 0.011 | 0.123 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.079 0.021 CID_41322 | ||
| 0.147 | 0.036 | 0.147 | Expectorant | 0.135 0.042 CID_41322 | ||
| 0.162 | 0.053 | 0.163 | Tubulin antagonist | 0.163 0.052 CID_41322 | CID_41322 | |
| 0.162 | 0.053 | 0.162 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.168 | 0.059 | 0.248 | Interferon gamma antagonist | 0.248 0.029 CID_41322 | CID_41322 | |
| 0.119 | 0.016 | 0.119 | Carbamoyl phosphate synthetase inhibitor | 0.073 0.033 CID_41322 | ||
| 0.243 | 0.141 | 0.298 | Vasodilator, coronary | 0.298 0.089 CID_41322 | CID_41322 | |
| 0.238 | 0.137 | 0.238 | Vasodilator, peripheral | 0.219 0.155 CID_41322 | ||
| 0.127 | 0.026 | 0.127 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.078 0.053 CID_41322 | ||
| 0.142 | 0.041 | 0.142 | Ferrochelatase inhibitor | |||
| 0.113 | 0.015 | 0.113 | Biliverdin reductase inhibitor | 0.057 0.044 CID_41322 | ||
| 0.17 | 0.073 | 0.17 | Growth hormone agonist | 0.13 0.107 CID_41322 | ||
| 0.117 | 0.02 | 0.117 | Glycine receptor antagonist | 0.112 0.023 CID_41322 | ||
| 0.275 | 0.18 | 0.275 | Calcium channel L-type activator | |||
| 0.136 | 0.041 | 0.136 | Protein kinase C gamma inhibitor | 0.106 0.067 CID_41322 | ||
| 0.133 | 0.041 | 0.133 | GABA C receptor antagonist | 0.092 0.091 CID_41322 | ||
| 0.097 | 0.005 | 0.097 | Glucose-6-phosphate isomerase inhibitor | 0.063 0.016 CID_41322 | ||
| 0.153 | 0.062 | 0.153 | Cell wall synthesis inhibitor | |||
| 0.146 | 0.056 | 0.146 | Heat shock protein 70 antagonist | |||
| 0.133 | 0.043 | 0.133 | Mucolytic | |||
| 0.106 | 0.018 | 0.106 | Glycine receptor agonist | 0.086 0.032 CID_41322 | ||
| 0.106 | 0.02 | 0.168 | T cell inhibitor | 0.168 0.009 CID_41322 | CID_41322 | |
| 0.273 | 0.187 | 0.526 | Cyclophilin D inhibitor | 0.526 0.043 CID_41322 | CID_41322 | |
| 0.213 | 0.127 | 0.213 | Lipoxygenase inhibitor | |||
| 0.139 | 0.055 | 0.139 | Aldehyde dehydrogenase inhibitor | 0.104 0.091 CID_41322 | ||
| 0.198 | 0.114 | 0.276 | Hypoglycemic | 0.276 0.062 CID_41322 | CID_41322 | |
| 0.122 | 0.04 | 0.122 | Sphingomyelinase inhibitor | 0.097 0.063 CID_41322 | ||
| 0.109 | 0.026 | 0.109 | Glutamate dehydrogenase inhibitor | 0.09 0.037 CID_41322 | ||
| 0.095 | 0.013 | 0.095 | Glutamate (mGluR6) antagonist | 0.078 0.026 CID_41322 | ||
| 0.097 | 0.017 | 0.097 | Acyl-CoA dehydrogenase inhibitor | 0.054 0.039 CID_41322 | ||
| 0.095 | 0.016 | 0.095 | Androgen agonist | 0.076 0.026 CID_41322 | ||
| 0.145 | 0.066 | 0.195 | Amylase inhibitor | 0.195 0.046 CID_41322 | CID_41322 | |
| 0.119 | 0.041 | 0.119 | GABA C receptor rho-1 antagonist | |||
| 0.134 | 0.057 | 0.134 | CC chemokine 6 receptor antagonist | |||
| 0.089 | 0.012 | 0.102 | Glucosylceramidase inhibitor | 0.102 0.008 CID_41322 | CID_41322 | |
| 0.185 | 0.11 | 0.319 | Free radical scavenger | 0.319 0.047 CID_41322 | CID_41322 | |
| 0.08 | 0.008 | 0.08 | Adenylate cyclase 1 inhibitor | 0.042 0.039 CID_41322 | ||
| 0.111 | 0.039 | 0.111 | Protein kinase C zeta inhibitor | 0.089 0.067 CID_41322 | ||
| 0.088 | 0.021 | 0.088 | Purinergic P2X1 antagonist | 0.056 0.05 CID_41322 | ||
| 0.088 | 0.022 | 0.088 | Argininosuccinate synthase inhibitor | |||
| 0.078 | 0.012 | 0.078 | Alpha-mannosidase inhibitor | 0.075 0.014 CID_41322 | ||
| 0.193 | 0.127 | 0.193 | Interleukin agonist | |||
| 0.089 | 0.024 | 0.089 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.109 | 0.044 | 0.109 | Alcohol dehydrogenase inhibitor | |||
| 0.115 | 0.051 | 0.115 | DOPA decarboxylase inhibitor | |||
| 0.076 | 0.012 | 0.151 | Estrogen receptor alpha agonist | 0.151 0.005 CID_41322 | CID_41322 | |
| 0.084 | 0.021 | 0.383 | Estrogen agonist | 0.383 0.004 CID_41322 | CID_41322 | |
| 0.115 | 0.053 | 0.141 | AMP-activated protein kinase stimulant | 0.141 0.034 CID_41322 | CID_41322 | |
| 0.146 | 0.083 | 0.146 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.157 | 0.095 | 0.157 | Lipocortins synthesis antagonist | |||
| 0.079 | 0.017 | 0.079 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.076 | 0.014 | 0.077 | Topoisomerase II beta inhibitor | 0.077 0.014 CID_41322 | CID_41322 | |
| 0.218 | 0.158 | 0.401 | Apoptosis antagonist | 0.401 0.038 CID_41322 | CID_41322 | |
| 0.138 | 0.079 | 0.138 | Pregnane X receptor agonist | |||
| 0.093 | 0.035 | 0.093 | Estrogen-related receptor beta agonist | |||
| 0.107 | 0.049 | 0.107 | Prolactin inhibitor | |||
| 0.147 | 0.09 | 0.147 | Heat shock protein 90 alpha antagonist | |||
| 0.111 | 0.055 | 0.111 | Beta glucuronidase inhibitor | 0.103 0.065 CID_41322 | ||
| 0.093 | 0.038 | 0.093 | Na+ K+ transporting ATPase inhibitor | 0.089 0.042 CID_41322 | ||
| 0.067 | 0.013 | 0.067 | Mannosidase inhibitor | 0.063 0.015 CID_41322 | ||
| 0.071 | 0.018 | 0.071 | Aconitate hydratase inhibitor | |||
| 0.085 | 0.032 | 0.088 | HIV-1 integrase (3'-Processing) inhibitor | 0.088 0.031 CID_41322 | CID_41322 | |
| 0.072 | 0.02 | 0.072 | Sphingosine kinase 2 inhibitor | |||
| 0.174 | 0.122 | 0.174 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.074 | 0.022 | 0.079 | Alpha tubulin antagonist | 0.079 0.02 CID_41322 | CID_41322 | |
| 0.16 | 0.108 | 0.16 | Psychostimulant | |||
| 0.103 | 0.053 | 0.103 | Glutamate (mGluR7) agonist | |||
| 0.063 | 0.014 | 0.063 | Progesterone antagonist | |||
| 0.054 | 0.005 | 0.081 | Sodium/glucose cotransporter 2 inhibitor | 0.081 0.004 CID_41322 | CID_41322 | |
| 0.17 | 0.121 | 0.17 | Aryl hydrocarbon receptor agonist | |||
| 0.086 | 0.037 | 0.086 | Aminopeptidase I inhibitor | |||
| 0.088 | 0.04 | 0.088 | Keratolytic | |||
| 0.089 | 0.041 | 0.089 | Porphobilinogen synthase inhibitor | |||
| 0.121 | 0.074 | 0.121 | Cathepsin H inhibitor | |||
| 0.087 | 0.04 | 0.087 | Telomerase inhibitor | |||
| 0.09 | 0.044 | 0.09 | D-Ala-D-Ala ligase inhibitor | |||
| 0.229 | 0.183 | 0.229 | 15-Lipoxygenase inhibitor | |||
| 0.082 | 0.036 | 0.082 | HIV-1 integrase inhibitor | |||
| 0.122 | 0.076 | 0.122 | Toll-Like receptor 2 antagonist | |||
| 0.095 | 0.05 | 0.095 | Ornithine decarboxylase inhibitor | |||
| 0.085 | 0.039 | 0.085 | Histidine decarboxylase inhibitor | |||
| 0.071 | 0.028 | 0.071 | Heat shock protein 90 beta antagonist | |||
| 0.094 | 0.052 | 0.094 | Histamine N-methyltransferase inhibitor | |||
| 0.07 | 0.028 | 0.07 | Calcium channel P-type blocker | |||
| 0.09 | 0.051 | 0.09 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.082 | 0.042 | 0.082 | Glutamate decarboxylase inhibitor | |||
| 0.178 | 0.139 | 0.178 | Spasmolytic | 0.167 0.147 CID_41322 | ||
| 0.088 | 0.05 | 0.088 | mTOR complex 2 inhibitor | 0.085 0.057 CID_41322 | ||
| 0.047 | 0.009 | 0.047 | Ceramide glucosyltransferase inhibitor | |||
| 0.066 | 0.029 | 0.066 | Sphingosine kinase inhibitor | |||
| 0.076 | 0.039 | 0.076 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.05 | 0.013 | 0.05 | Fumarate hydratase inhibitor | |||
| 0.077 | 0.04 | 0.077 | Phospholipase D inhibitor | 0.076 0.041 CID_41322 | ||
| 0.059 | 0.024 | 0.062 | Heparanase inhibitor | 0.062 0.02 CID_41322 | CID_41322 | |
| 0.08 | 0.045 | 0.08 | MAP kinase kinase 7 inhibitor | |||
| 0.107 | 0.072 | 0.127 | Interleukin 2 antagonist | 0.127 0.035 CID_41322 | CID_41322 | |
| 0.095 | 0.061 | 0.095 | Bile acid receptor antagonist | |||
| 0.053 | 0.019 | 0.053 | Geranyltranstransferase inhibitor | |||
| 0.043 | 0.009 | 0.043 | Estrogen-related receptor beta antagonist | 0.031 0.026 CID_41322 | ||
| 0.052 | 0.019 | 0.4 | Estrogen receptor beta agonist | 0.4 0.003 CID_41322 | CID_41322 | |
| 0.081 | 0.048 | 0.081 | CYP2A6 inhibitor | |||
| 0.095 | 0.063 | 0.095 | Phosphodiesterase 6D inhibitor | |||
| 0.038 | 0.007 | 0.058 | Sodium/glucose cotransporter inhibitor | 0.058 0.004 CID_41322 | CID_41322 | |
| 0.048 | 0.018 | 0.048 | Acid-sensing ion channel blocker | |||
| 0.056 | 0.026 | 0.056 | CD45 antagonist | |||
| 0.07 | 0.039 | 0.07 | MDM2 inhibitor | |||
| 0.057 | 0.027 | 0.057 | Phosphorylase inhibitor | 0.042 0.035 CID_41322 | ||
| 0.037 | 0.009 | 0.037 | Purinergic P2Y15 antagonist | 0.028 0.022 CID_41322 | ||
| 0.048 | 0.019 | 0.048 | Dopamine D5 agonist | |||
| 0.046 | 0.019 | 0.049 | Kainate receptor agonist | 0.049 0.015 CID_41322 | CID_41322 | |
| 0.082 | 0.056 | 0.128 | Thioredoxin reductase inhibitor | 0.128 0.014 CID_41322 | CID_41322 | |
| 0.047 | 0.021 | 0.047 | Thymidine kinase inhibitor | |||
| 0.075 | 0.05 | 0.075 | Vanilloid 4 agonist | |||
| 0.033 | 0.008 | 0.033 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.021 CID_41322 | ||
| 0.037 | 0.013 | 0.037 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.032 | 0.009 | 0.032 | Hedgehog signaling activator | |||
| 0.111 | 0.088 | 0.111 | Cyclooxygenase 3 inhibitor | |||
| 0.026 | 0.004 | 0.026 | Antibiotic Anthracycline-like | 0.021 0.009 CID_41322 | ||
| 0.027 | 0.005 | 0.027 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.05 | 0.028 | 0.05 | Thymidylate synthase inhibitor | |||
| 0.07 | 0.048 | 0.07 | Protein kinase C beta inhibitor | |||
| 0.068 | 0.047 | 0.068 | Exportin-1 inhibitor | |||
| 0.113 | 0.092 | 0.113 | Antibacterial (Helicobacter pylori) | |||
| 0.03 | 0.01 | 0.03 | Adenosine kinase inhibitor | 0.02 0.016 CID_41322 | ||
| 0.024 | 0.004 | 0.024 | Thromboxane A2 agonist | 0.017 0.008 CID_41322 | ||
| 0.045 | 0.026 | 0.045 | Guanylate cyclase inhibitor | |||
| 0.067 | 0.048 | 0.067 | Glutamate (mGluR7) antagonist | |||
| 0.054 | 0.036 | 0.056 | Protein 50S ribosomal subunit inhibitor | 0.056 0.034 CID_41322 | CID_41322 | |
| 0.043 | 0.025 | 0.043 | Sphingosine kinase 1 inhibitor | |||
| 0.054 | 0.036 | 0.054 | Ornithine carbamoyltransferase inhibitor | |||
| 0.094 | 0.077 | 0.094 | Carbonic anhydrase XV inhibitor | |||
| 0.054 | 0.037 | 0.054 | Leukotriene B4 antagonist | |||
| 0.089 | 0.073 | 0.089 | Aminopeptidase B inhibitor | |||
| 0.034 | 0.019 | 0.034 | ATP citrate lysase inhibitor | 0.029 0.026 CID_41322 | ||
| 0.056 | 0.041 | 0.056 | Fatty acid synthase inhibitor | |||
| 0.036 | 0.023 | 0.036 | Phosphoglycerate kinase inhibitor | |||
| 0.04 | 0.026 | 0.04 | Alpha 1d adrenoreceptor agonist | |||
| 0.196 | 0.183 | 0.252 | Antithrombotic | 0.252 0.124 CID_41322 | CID_41322 | |
| 0.122 | 0.109 | 0.122 | Insulin secretagoues | |||
| 0.032 | 0.019 | 0.032 | Cyclophilin A inhibitor | |||
| 0.052 | 0.039 | 0.052 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.038 | 0.026 | 0.038 | Vanilloid 3 antagonist | |||
| 0.037 | 0.025 | 0.037 | Glutamate (mGluR3) antagonist | |||
| 0.072 | 0.061 | 0.072 | GABA B receptor agonist | |||
| 0.019 | 0.009 | 0.019 | Telomerase stimulant | |||
| 0.045 | 0.035 | 0.045 | Adenosine deaminase inhibitor | |||
| 0.018 | 0.008 | 0.018 | S-adenosyl-L-homocysteine hydrolase inhibitor | |||
| 0.037 | 0.027 | 0.037 | Glutamate (mGluR8) agonist | |||
| 0.024 | 0.014 | 0.024 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.088 | 0.078 | 0.088 | Carbonic anhydrase III inhibitor | |||
| 0.024 | 0.015 | 0.024 | Prostaglandin EP2 agonist | 0.021 0.017 CID_41322 | ||
| 0.056 | 0.047 | 0.056 | Lipocortins synthesis agonist | 0.054 0.053 CID_41322 | ||
| 0.073 | 0.064 | 0.073 | Interferon agonist | |||
| 0.044 | 0.036 | 0.068 | Microtubule stabilization | 0.068 0.008 CID_41322 | CID_41322 | |
| 0.14 | 0.132 | 0.14 | P-glycoprotein inhibitor | |||
| 0.146 | 0.138 | 0.152 | Insulin sensitizer | 0.152 0.13 CID_41322 | CID_41322 | |
| 0.025 | 0.018 | 0.025 | Vanilloid 2 agonist | |||
| 0.027 | 0.02 | 0.027 | Uridine phosphorylase inhibitor | |||
| 0.069 | 0.063 | 0.069 | GABA aminotransferase inhibitor | |||
| 0.016 | 0.01 | 0.016 | Purinergic P2Y1 agonist | |||
| 0.038 | 0.033 | 0.038 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.054 | 0.049 | 0.054 | Pregnane X receptor antagonist | |||
| 0.018 | 0.013 | 0.018 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.022 | 0.017 | 0.022 | Isoleucine-tRNA ligase inhibitor | 0.021 0.019 CID_41322 | ||
| 0.082 | 0.077 | 0.082 | Thioredoxin inhibitor | |||
| 0.124 | 0.119 | 0.124 | Mcl-1 antagonist | |||
| 0.012 | 0.007 | 0.012 | Thromboxane agonist | |||
| 0.138 | 0.134 | 0.138 | Neurotensin receptor agonist | |||
| 0.039 | 0.035 | 0.039 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.022 | 0.017 | 0.022 | Prostaglandin F2 alpha agonist | |||
| 0.087 | 0.083 | 0.087 | Gastric antisecretory | |||
| 0.025 | 0.022 | 0.025 | NMDA 2D receptor antagonist | |||
| 0.06 | 0.056 | 0.06 | Transcription factor RelA inhibitor | |||
| 0.039 | 0.037 | 0.039 | GABA B receptor antagonist | |||
| 0.056 | 0.053 | 0.088 | Selectin antagonist | 0.088 0.033 CID_41322 | CID_41322 | |
| 0.057 | 0.056 | 0.057 | Leukotriene antagonist | |||
| 0.015 | 0.014 | 0.015 | Ileal bile acid transport inhibitor | |||
| 0.111 | 0.11 | 0.111 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.03 | 0.035 | 0.037 | Tubulin agonist | 0.037 0.019 CID_41322 | CID_41322 | |
| 0.083 | 0.089 | 0.11 | Monophenol monooxygenase inhibitor | 0.11 0.068 CID_41322 | CID_41322 | |
| 0.03 | 0.038 | 0.054 | Antibiotic Aminoglycoside-like | 0.054 0.011 CID_41322 | CID_41322 | |
| 0.017 | 0.029 | 0.022 | Adenosine A1 receptor agonist | 0.022 0.019 CID_41322 | CID_41322 | |
| 0.011 | 0.023 | 0.049 | Progesterone agonist | 0.049 0.005 CID_41322 | CID_41322 | |
| 0.065 | 0.085 | 0.08 | Androgen antagonist | 0.08 0.065 CID_41322 | CID_41322 | |
| 0.015 | 0.043 | 0.028 | Protein 30S ribosomal subunit inhibitor | 0.028 0.014 CID_41322 | CID_41322 | |
| 0.112 | 0.166 | 0.332 | Interleukin 6 antagonist | 0.332 0.011 CID_41322 | CID_41322 | |
| 0.008 | 0.07 | 0.02 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.02 0.014 CID_41322 | CID_41322 | |
| 0.011 | 0.1 | 0.067 | Glucocorticoid antagonist | 0.067 0.009 CID_41322 | CID_41322 | |
| 0.085 | 0.256 | 0.227 | Platelet antagonist | 0.227 0.084 CID_41322 | CID_41322 | |
| 0.076 | 0.253 | 0.166 | Platelet adhesion inhibitor | 0.166 0.091 CID_41322 | CID_41322 | |
| 0.013 | 0.295 | 0.057 | Mineralocorticoid receptor antagonist | 0.057 0.023 CID_41322 | CID_41322 | |
| 0.039 | 0.471 | 0.193 | Vasodilator | 0.193 0.11 CID_41322 | CID_41322 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |